CLINICAL_TRIALS ClinicalTrials.gov record update

An Observational, Prospective Cohort Study to Evaluate the Safety and Effectiveness of Remsima® in the Treatment of Inflammatory Bowel Disease Among Saudi Arabia Patients Diagnosed With Crohn's Disease, Ulcerative Colitis, or Fistulizing CD

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03452501
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:18.107094+00:00
Published At: 2021-02-23T00:00:00+00:00
Record Updated At: 2021-02-23
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Inflammatory Bowel Diseases", "Crohn Disease", "Fistulizing Crohn\u0027s Disease", "Ulcerative Colitis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2021-02-23"
protocolSection.identificationModule.nctId: "NCT03452501"
protocolSection.identificationModule.officialTitle: "An Observational, Prospective Cohort Study to Evaluate the Safety and Effectiveness of Remsima\u00ae in the Treatment of Inflammatory Bowel Disease Among Saudi Arabia Patients Diagnosed With Crohn\u0027s Disease, Ulcerative Colitis, or Fistulizing CD"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: []
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.